529 filings
Page 2 of 27
4
ied80rmm7haghikrxv
9 Feb 24
Syndax Pharmaceuticals / Martin H. Jr. Huber ownership change
4:04pm
4
mjfqccg ao2
9 Feb 24
Syndax Pharmaceuticals / Jennifer Jarrett ownership change
4:04pm
4
trk5j9 hng7p7j5a4d
9 Feb 24
Syndax Pharmaceuticals / Keith Katkin ownership change
4:04pm
4
dq9 evijk40r3
9 Feb 24
Syndax Pharmaceuticals / William Meury ownership change
4:04pm
4
nuywo lkcz
9 Feb 24
Syndax Pharmaceuticals / Briggs Morrison ownership change
4:04pm
4
hux2ulohnzpyyh3mc45
9 Feb 24
Syndax Pharmaceuticals / Dennis Podlesak ownership change
4:04pm
4
wab7c24tl71vizmb
9 Feb 24
Syndax Pharmaceuticals / Pierre Legault ownership change
4:04pm
SC 13G/A
jgpks
8 Feb 24
Syndax Pharmaceuticals / WELLINGTON MANAGEMENT ownership change
10:18am
SC 13G/A
4s1db
25 Jan 24
Syndax Pharmaceuticals / BlackRock ownership change
4:59pm
SC 13G/A
1ueo3q8bq2jlsvo
25 Jan 24
Syndax Pharmaceuticals / STATE STREET ownership change
11:20am
8-K
95y86gx kdd1
20 Dec 23
Syndax Announces Closing of Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
8:40am
8-K
ab572k2
15 Dec 23
Entry into a Material Definitive Agreement
5:29pm
424B5
00yw3yrgfcldmg
15 Dec 23
Prospectus supplement for primary offering
5:29pm
424B5
0lratufrhd6
14 Dec 23
Prospectus supplement for primary offering
4:30pm
8-K
vzura vg7
12 Dec 23
Other Events
4:05pm
UPLOAD
srr3at
7 Dec 23
Letter from SEC
12:00am
CORRESP
m4yaq
28 Nov 23
Correspondence with SEC
12:00am
UPLOAD
mat0qo 3qv6b1t3
13 Nov 23
Letter from SEC
12:00am
8-K
s67zww zsc
2 Nov 23
Syndax Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update
4:03pm